Completed PHASE2 INTERVENTIONAL 1-arm NCT06521775

An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastatic Adenoid Cystic Carcinoma

Pilot Study Evaluating PSMA PET For Metastatic Adenoid Cystic Carcinoma

Sponsor: Mayo Clinic

Conditions Metastatic Adenoid Cystic Carcinoma

Interventions Computed Tomography Electronic Health Record Review Ga-68 PSMA-11 Positron Emission Tomography

Updated 5 times since 2024 Last updated: Sep 11, 2025 Started: Aug 12, 2024 Primary completion: Aug 12, 2025 Completion: Aug 12, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Metastatic Adenoid Cystic Carcinoma and is currently completed. Mayo Clinic leads this study, which shows 5 recorded versions since 2024 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Oct 2025 — Present [monthly]

Completed PHASE2

Status: Enrolling By Invitation → Completed
Apr 2025 — Oct 2025 [monthly]

Enrolling By Invitation PHASE2
Oct 2024 — Apr 2025 [monthly]

Enrolling By Invitation PHASE2

Status: Not Yet Recruiting → Enrolling By Invitation
Sep 2024 — Oct 2024 [monthly]

Not Yet Recruiting PHASE2
Aug 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mayo Clinic

Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States